封面
市場調查報告書
商品編碼
1588342

震盪市場規模、佔有率和趨勢分析報告:按評估/處理、最終用途、地區和細分市場進行預測,2025-2030 年

Concussion Market Size, Share & Trends Analysis Report By Assessment And Treatment (Diagnosis, Treatment), By End Use (Hospitals, Diagnostic Centers) By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

震盪市場成長與趨勢:

Grand View Research, Inc.最新報告顯示,預計2030年全球腦震盪市場規模將達93.1億美元,2025年至2030年複合年成長率為6.0%。

大腦損傷數量的增加導致腦震盪等相關疾病的高發,這對市場產生了積極的推動作用。

繼跌倒和運動傷害之後,車禍是腦震盪患者住院的主要原因。美國,每年估計有 56,000 名老年人因跌倒事故造成的輕度頭部受傷(腦震盪)而住院。預計這將推動預測期內的市場成長。

此外,世界各地正在進行多項宣傳活動和舉措,以提高對腦震蕩的認知,這也有助於整體市場的成長。例如,國防和退伍軍人腦損傷中心為平民和軍事人員提供線上教育,以了解創傷性腦損傷,以促進對軍人和退伍軍人的最佳護理。

此外,主要企業正在採取聯盟和新產品發布等各種策略來增加市場佔有率。預計這將推動預測期內的市場成長。例如,2019年,Nihon Kohden在美國推出了一款無線腦電圖(EEG)耳機,旨在評估昏迷患者的大腦活動。

震盪市場報告亮點

  • 診斷細分市場佔據主導地位,2024 年收益佔有率最大,為 72.2%。由於診斷技術的進步和腦震盪發生率的增加,診斷領域預計在未來幾年將顯著成長。
  • 由於人們對腦震盪相關風險的認知不斷提高以及醫院致力於提供先進的診斷和治療解決方案,醫院細分市場在 2024 年佔據最大的市場佔有率,達到 39.1%。
  • 北美震盪市場主導全球整體市場,2024年佔銷售佔有率的60.9%。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章震盪市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 震盪市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 震盪市場:評估/治療預估/趨勢分析

  • 細分儀表板
  • 震盪市場:評估與治療變異分析
  • 震盪後市前景評估及處理
  • 2018-2030年市場規模、預測及趨勢分析
  • 治療
  • 診斷

第5章震盪市場:最終用途估計和趨勢分析

  • 細分儀表板
  • 震盪市場:最終用途變化分析
  • 按最終用途分類的震盪市場前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 醫院
  • 診斷中心
  • 神經科門診
  • 研究中心
  • 其他

第6章 震盪行情:區域預估與趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模、預測趨勢分析:
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 市場參與企業分類
  • 主要市場參與企業的最新趨勢和影響分析
  • 2024 年企業市場佔有率分析
  • 主要企業簡介
    • NIHON KOHDEN CORPORATION
    • Compumedics Limited
    • INTEGRA LIFESCIENCES
    • BioDirection(NanoDx)
    • Oculogica
    • Abbott
    • BrainScope Company Inc.
    • BIOMERIEUX
    • Magstim
    • Advanced Brain Monitoring, Inc.
    • Healius Limited
Product Code: GVR-4-68039-154-2

Concussion Market Growth & Trends:

The global concussion market size is anticipated to reach USD 9.31 billion by 2030, expanding at a CAGR of 6.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing number of injuries being caused to the brain resulting in a high prevalence of associated disorders such as concussion is driving the market in a positive manner.

Falls and sports injuries followed by motor vehicle accidents are the leading causes of hospitalization in patients with concussion. As per the Centers for Disease Control and Prevention (CDC), an estimated 56,000 seniors are hospitalized every year as a result of mild head injuries (concussions) suffered due to accidental falls. This is anticipated to boost market growth over the forecast period.

In addition, several awareness campaigns and initiatives throughout the world to raise awareness related to concussion are collectively responsible for market growth. For instance, the Defense and Veterans Brain Injury Center offers online education for both civilians and military officers to learn about traumatic brain injuries in order to promote the best possible care for service members and veterans.

Furthermore, key players are adopting various strategies such as collaborations and new product launches to increase their market share. This is likely to boost market growth during the forecast period. For instance, in 2019, Nihon Kohden launched a wireless Electroencephalogram (EEG) headset in the U.S, which is intended to assess brain activity in unconscious patients.

Concussion Market Report Highlights:

  • The diagnosis segment dominated the market and accounted for the largest revenue share of 72.2% in 2024. The diagnosis segment is projected to experience substantial growth in the coming years, driven by advancements in diagnostic technologies and an increasing incidence of concussions.
  • The hospital segment accounted for the largest market share of 39.1% in 2024, driven by growing awareness of concussion-related risks and hospitals' commitment to delivering advanced diagnostic and treatment solutions.
  • The concussion market in North America dominated the overall global market and accounted for 60.9% of revenue share in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Assessment and treatment
    • 1.2.2. End Use
    • 1.2.3. Regional Scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Concussion Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing incidence of mild traumatic brain injuries or concussions
      • 3.2.1.2. Rising number of road accidents and sports injuries
      • 3.2.1.3. Technological advancements in concussion devices
      • 3.2.1.4. Growing focus on research activities
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost associated with concussion treatment
      • 3.2.2.2. Lack of awareness in people regarding concussion
  • 3.3. Concussion Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Concussion Market: Assessment and Treatment Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Concussion Market: Assessment and Treatment Movement Analysis
  • 4.3. Concussion Market by Assessment and Treatment Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Treatment
    • 4.5.1. Treatment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Diagnosis
    • 4.6.1. Diagnosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Concussion Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Concussion Market: End Use Movement Analysis
  • 5.3. Concussion Market by End Use Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Hospitals
    • 5.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Diagnostic Centers
    • 5.6.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Neurologic Clinics
    • 5.7.1. Neurologic Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Research centers
    • 5.8.1. Neurologic Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Concussion Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Dashboard
  • 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework/ reimbursement structure
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Recent Developments & Impact Analysis by Key Market Participants
  • 7.3. Company Market Share Analysis, 2024
  • 7.4. Key Company Profiles
    • 7.4.1. NIHON KOHDEN CORPORATION
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Compumedics Limited
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. INTEGRA LIFESCIENCES
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. BioDirection (NanoDx)
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Oculogica
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Abbott
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. BrainScope Company Inc.
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. BIOMERIEUX
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Magstim
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Advanced Brain Monitoring, Inc.
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. Healius Limited
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America concussion market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 4 North America concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 5 U.S. concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 6 U.S. concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 8 Canada concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Mexico concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 10 Mexico concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe concussion market, by region, 2018 - 2030 (USD Million)
  • Table 12 Europe concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 13 Europe concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Germany concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 15 Germany concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 16 UK concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 17 UK concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 18 France concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 19 France concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Italy concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 21 Italy concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Spain concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 23 Spain concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Denmark concussion market, by assessment and treatment, (USD Million)
  • Table 25 Denmark concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Sweden concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 27 Sweden concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Norway concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 29 Norway concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific concussion market, by region, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 33 China concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 34 China concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Japan concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 36 Japan concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 37 India concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 38 India concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 39 South Korea concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 40 South Korea concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Australia concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 42 Australia concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Thailand concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 44 Thailand concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Latin America concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 46 Latin America concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Brazil concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 48 Brazil concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Argentina concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 50 Argentina concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 51 MEA concussion market, by region, 2018 - 2030 (USD Million)
  • Table 52 MEA concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 53 MEA concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 54 South Africa concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 55 South Africa concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Saudi Arabia concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 58 UAE concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 59 UAE concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Kuwait concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 61 Kuwait concussion market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Concussion market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain-based size & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market snapshot (global and regional)
  • Fig. 8 Assessment and treatment segment and end use segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Magnetic resonance imaging and concussion market, value, 2024 (USD Billion)
  • Fig. 11 Market dynamics
  • Fig. 12 Traumatic brain injury statistics per year, U.S.
  • Fig. 13 Serious injuries due to road accidents by country in 2024
  • Fig. 14 Sports product-related injuries in the U.S. in 2022 & 2023
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 PESTLE analysis
  • Fig. 17 Concussion market: Assessment and treatment outlook and key takeaways
  • Fig. 18 Concussion market: Assessment and treatment movement analysis
  • Fig. 19 Diagnosis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Computed tomography (CT) scan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Magnetic resonance imaging (MRI) devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Electroencephalography (EEG) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Concussion market: End use outlook and key takeaways
  • Fig. 26 Concussion market: End use movement analysis
  • Fig. 27 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Diagnostic centers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Neurologic clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Research centers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Concussion market revenue by region, 2024 & 2030, (USD Million)
  • Fig. 33 Regional marketplace: Key takeaways
  • Fig. 34 Regional marketplace: Key takeaways
  • Fig. 35 North America concussion market, 2018 - 2030 (USD Million)
  • Fig. 36 Key country dynamics
  • Fig. 37 U.S. concussion market, 2018 - 2030 (USD Million)
  • Fig. 38 Key country dynamics
  • Fig. 39 Canada concussion market, 2018 - 2030 (USD Million)
  • Fig. 40 Europe concussion market, 2018 - 2030 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 UK concussion market, 2018 - 2030 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Germany concussion market, 2018 - 2030 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 France concussion market, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Italy concussion market, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Spain concussion market, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Sweden concussion market, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Denmark concussion market, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Norway concussion market, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific concussion market, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Japan concussion market, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 China concussion market, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 India concussion market, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Australia concussion market, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 South Korea concussion market, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Thailand concussion market, 2018 - 2030 (USD Million)
  • Fig. 70 Latin America concussion market, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Brazil concussion market, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Mexico concussion market, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Argentina concussion market, 2018 - 2030 (USD Million)
  • Fig. 77 Middle East & Africa concussion market, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 South Africa concussion market, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Saudi Arabia concussion market, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 UAE concussion market, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Kuwait concussion market, 2018 - 2030 (USD Million)
  • Fig. 86 Key company categorization
  • Fig. 87 Concussion market share analysis, 2024
  • Fig. 88 Strategic framework